Welcome back to Health Unlocked: The Power of Salutogenesis, where we explore cutting-edge ideas shaping the future of healthcare. In this episode, Jasen Petersen discusses how Ion Biotechnology is pivoting its US market entry strategy amidst shifting crypto and DeSci (Decentralized Science) market conditions.

Instead of pursuing the costly and complex 510k regulatory pathway immediately, he reveals a new plan centered on launching the Ion Gel as a Class 1 medical device or even as a cosmetic product, leveraging the terrain support concept. This approach not only allows faster access to the US market and clinical data generation but also provides a foundation for stronger future regulatory submissions. Along the way, he covers the importance of academic publication, community involvement via token funding, and maintaining transparency as the project evolves.

Tune in to get a real-time look at how innovation, regulation, and community engagement intersect in biotech.

Timestamps:

00:00 Finding a cost-effective FDA strategy

06:17 FDA classification and product function

09:33 Understanding product claims and regulations

12:51 Preventing diabetic foot ulcers

17:15 Overview of the research papers

21:30 Launching token before DAO

24:50 Presenting research and generating interest

27:22 FDA reclassification and strategy

31:37 Using real-world data for strategy

35:26 Navigating FDA classification challenges

38:09 Connecting with Jason and updates

39:50 Wrapping up the episode

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/